ID   KLY_TANFA               Reviewed;         472 AA.
AC   D0EM77;
DT   19-MAR-2014, integrated into UniProtKB/Swiss-Prot.
DT   19-MAR-2014, sequence version 2.
DT   07-APR-2021, entry version 52.
DE   RecName: Full=Karilysin;
DE            EC=3.4.24.-;
DE   AltName: Full=Matrix metalloprotease-like enzyme;
DE            Short=MMP-like enzyme;
DE   Contains:
DE     RecName: Full=Karilysin long form Kly38;
DE   Contains:
DE     RecName: Full=Karilysin short form Kly18;
DE   Flags: Precursor;
GN   Name=kly; OrderedLocusNames=BFO_2683;
OS   Tannerella forsythia (strain ATCC 43037 / JCM 10827 / FDC 338) (Bacteroides
OS   forsythus).
OC   Bacteria; Bacteroidetes; Bacteroidia; Bacteroidales; Tannerellaceae;
OC   Tannerella.
OX   NCBI_TaxID=203275;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], SEQUENCE REVISION, PARTIAL PROTEIN
RP   SEQUENCE, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, ACTIVITY
RP   REGULATION, IDENTIFICATION BY MASS SPECTROMETRY, AUTOCATALYTIC CLEAVAGE,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF TYR-35 AND GLU-156.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=19919176; DOI=10.1515/bc.2010.009;
RA   Karim A.Y., Kulczycka M., Kantyka T., Dubin G., Jabaiah A., Daugherty P.S.,
RA   Thogersen I.B., Enghild J.J., Nguyen K.A., Potempa J.;
RT   "A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal
RT   pathogen Tannerella forsythia ATCC 43037.";
RL   Biol. Chem. 391:105-117(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RA   Dewhirst F., Tanner A., Izard J., Brinkac L., Durkin A.S., Hostetler J.,
RA   Shetty J., Torralba M., Gill S., Nelson K.;
RT   "Complete sequence of Tannerella forsythia ATCC 43037.";
RL   Submitted (DEC-2011) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=20375548; DOI=10.1159/000281881;
RA   Koziel J., Karim A.Y., Przybyszewska K., Ksiazek M., Rapala-Kozik M.,
RA   Nguyen K.A., Potempa J.;
RT   "Proteolytic inactivation of LL-37 by karilysin, a novel virulence
RT   mechanism of Tannerella forsythia.";
RL   J. Innate Immun. 2:288-293(2010).
RN   [4]
RP   FUNCTION, GENE NAME, AND MUTAGENESIS OF GLU-156.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=22287711; DOI=10.4049/jimmunol.1101240;
RA   Jusko M., Potempa J., Karim A.Y., Ksiazek M., Riesbeck K., Garred P.,
RA   Eick S., Blom A.M.;
RT   "A metalloproteinase karilysin present in the majority of Tannerella
RT   forsythia isolates inhibits all pathways of the complement system.";
RL   J. Immunol. 188:2338-2349(2012).
RN   [5]
RP   ACTIVITY REGULATION, AND INHIBITOR STUDIES.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=23119051; DOI=10.1371/journal.pone.0048537;
RA   Skottrup P.D., Sorensen G., Ksiazek M., Potempa J., Riise E.;
RT   "A phage display selected 7-mer peptide inhibitor of the Tannerella
RT   forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-
RT   Trp-Phe-Pro.";
RL   PLoS ONE 7:E48537-E48537(2012).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 35-201 IN COMPLEX WITH ZINC AND A
RP   TRIPEPTIDE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND ACTIVE SITE.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=21166898; DOI=10.1111/j.1365-2958.2010.07434.x;
RA   Cerda-Costa N., Guevara T., Karim A.Y., Ksiazek M., Nguyen K.A.,
RA   Arolas J.L., Potempa J., Gomis-Ruth F.X.;
RT   "The structure of the catalytic domain of Tannerella forsythia karilysin
RT   reveals it is a bacterial xenologue of animal matrix metalloproteinases.";
RL   Mol. Microbiol. 79:119-132(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 35-200 IN COMPLEX WITH ZINC AND A
RP   TETRAPEPTIDIC INHIBITOR, COFACTOR, AND ACTIVE SITE.
RC   STRAIN=ATCC 43037 / JCM 10827 / FDC 338;
RX   PubMed=23695557; DOI=10.1107/s1744309113007392;
RA   Guevara T., Ksiazek M., Skottrup P.D., Cerda-Costa N., Trillo-Muyo S.,
RA   de Diego I., Riise E., Potempa J., Gomis-Ruth F.X.;
RT   "Structure of the catalytic domain of the Tannerella forsythia matrix
RT   metallopeptidase karilysin in complex with a tetrapeptidic inhibitor.";
RL   Acta Crystallogr. F 69:472-476(2013).
CC   -!- FUNCTION: Metalloprotease able to cleave casein, gelatin, elastin,
CC       fibrinogen and fibronectin. Shows exclusive preference for hydrophobic
CC       residues, especially Leu, Tyr and Met, at the P1' position of
CC       substrates, and for Pro or Ala at P3. Can efficiently cleave the
CC       antimicrobial peptide LL-37 which is a component of the immune system,
CC       leading to a significant reduction of its bactericidal activity. Is
CC       also able to inhibit all pathways of the human complement system. The
CC       classical and lectin complement pathways are inhibited because of the
CC       efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3,
CC       and C4 by karilysin, whereas inhibition of the terminal pathway is
CC       caused by cleavage of C5. Thus, karilysin appears to be a major
CC       virulence factor of T.forsythia that contributes to evasion of the
CC       human immune response and periodontal disease. Seems to act
CC       synergistically with gingipains from the periodontal pathogen
CC       P.gingivalis present at the same sites of infection.
CC       {ECO:0000269|PubMed:19919176, ECO:0000269|PubMed:20375548,
CC       ECO:0000269|PubMed:21166898, ECO:0000269|PubMed:22287711}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:21166898, ECO:0000269|PubMed:23695557};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|PubMed:21166898,
CC       ECO:0000269|PubMed:23695557};
CC   -!- ACTIVITY REGULATION: Autoprocessing and proteolytic activity are
CC       completely inhibited by EDTA and 1,10-phenanthroline in vitro.
CC       Proteolytic activity is 3-fold enhanced by Ca(2+) due to stabilization
CC       of the protein structure but inhibited by an excess of Zn(2+)
CC       (PubMed:19919176). Inhibitory studies of karilysin identified several
CC       phage display-selected peptides with apparent inhibition constants (Ki)
CC       in the micromolar range, among which is the tetrapeptide SWFP (Ki=10.7
CC       uM) (PubMed:23119051). {ECO:0000269|PubMed:19919176,
CC       ECO:0000269|PubMed:23119051}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8 for casein degradation. Active in the broad pH range
CC         from 6.5 to 8.5. {ECO:0000269|PubMed:19919176};
CC       Temperature dependence:
CC         In the presence of CaCl(2), the enzyme is fully stable for up to 40
CC         minutes at 70 degrees Celsius, whereas karilysin incubated without
CC         calcium loses 50% of its activity within 30 minutes.
CC         {ECO:0000269|PubMed:19919176};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- PTM: Processes itself into the mature 18-kDa enzyme (Kly18) through
CC       sequential autoproteolytic cleavage at both the N- and C-termini.
CC       However, the maturation intermediate Kly38 is found to be more active
CC       than Kly18 and the rate for its processing is slow, which raises the
CC       question as to whether Kly38 is a physiologically relevant entity.
CC   -!- SIMILARITY: Belongs to the peptidase M10A family. {ECO:0000305}.
CC   -!- CAUTION: Sequence submitted to GenBank under accession ACW82491.1 does
CC       not completely correspond to the one described in the related article,
CC       which is the correct one. {ECO:0000305|PubMed:19919176}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CP003191; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CP003191; Type=Miscellaneous discrepancy; Note=Region of major discrepancy (238-386) presumably comes from incorrect genome shotgun sequence assembly of homologous regions with other proteases.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ856797; ACW82491.1; -; Genomic_DNA.
DR   EMBL; CP003191; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PDB; 2XS3; X-ray; 2.40 A; A/B=35-200.
DR   PDB; 2XS4; X-ray; 1.70 A; A=35-201.
DR   PDB; 4IN9; X-ray; 1.55 A; A=35-200.
DR   PDB; 4R3V; X-ray; 2.01 A; A/B=21-201.
DR   PDBsum; 2XS3; -.
DR   PDBsum; 2XS4; -.
DR   PDBsum; 4IN9; -.
DR   PDBsum; 4R3V; -.
DR   SMR; D0EM77; -.
DR   STRING; 203275.BFO_2661; -.
DR   MEROPS; M10.066; -.
DR   TCDB; 8.B.14.2.4; the sea anemone peptide toxin, class 1 (bgk) family.
DR   eggNOG; COG0265; Bacteria.
DR   eggNOG; COG5549; Bacteria.
DR   OMA; CHGINDE; -.
DR   EvolutionaryTrace; D0EM77; -.
DR   Proteomes; UP000005436; Chromosome.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   CDD; cd04278; ZnMc_MMP; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR008964; Invasin/intimin_cell_adhesion.
DR   InterPro; IPR033739; M10A_MMP.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001818; Pept_M10_metallopeptidase.
DR   InterPro; IPR021190; Pept_M10A.
DR   InterPro; IPR006026; Peptidase_Metallo.
DR   InterPro; IPR026444; Secre_tail.
DR   Pfam; PF00413; Peptidase_M10; 1.
DR   Pfam; PF18962; Por_Secre_tail; 1.
DR   PRINTS; PR00138; MATRIXIN.
DR   SMART; SM00235; ZnMc; 1.
DR   SUPFAM; SSF49373; SSF49373; 1.
DR   TIGRFAMs; TIGR04183; Por_Secre_tail; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Direct protein sequencing; Hydrolase;
KW   Metal-binding; Metalloprotease; Protease; Reference proteome; Secreted;
KW   Signal; Virulence; Zinc; Zymogen.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   PROPEP          21..34
FT                   /note="Activation peptide"
FT                   /id="PRO_0000425866"
FT   CHAIN           35..386
FT                   /note="Karilysin long form Kly38"
FT                   /id="PRO_0000425867"
FT   CHAIN           35..195
FT                   /note="Karilysin short form Kly18"
FT                   /id="PRO_0000425868"
FT   PROPEP          196..386
FT                   /note="Removed in short form"
FT                   /id="PRO_0000425869"
FT   PROPEP          387..472
FT                   /note="Removed in long form"
FT                   /id="PRO_0000425870"
FT   ACT_SITE        156
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:21166898, ECO:0000269|PubMed:23695557"
FT   METAL           102
FT                   /note="Zinc 1; via tele nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           104
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           117
FT                   /note="Zinc 1; via tele nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           133
FT                   /note="Zinc 1; via pros nitrogen"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           155
FT                   /note="Zinc 2; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           159
FT                   /note="Zinc 2; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   METAL           165
FT                   /note="Zinc 2; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:21166898,
FT                   ECO:0000269|PubMed:23695557"
FT   MUTAGEN         35
FT                   /note="Y->A: Hinders generation of active enzyme and
FT                   maturation process."
FT                   /evidence="ECO:0000269|PubMed:19919176"
FT   MUTAGEN         156
FT                   /note="E->A: Fails to autocatalytically process, to destroy
FT                   the bactericidal activity of human serum and to inhibit all
FT                   the complement pathways."
FT                   /evidence="ECO:0000269|PubMed:19919176,
FT                   ECO:0000269|PubMed:22287711"
FT   CONFLICT        136
FT                   /note="G -> D (in Ref. 1; ACW82491 and 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220..221
FT                   /note="LS -> PA (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        224..226
FT                   /note="TVQ -> IVE (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        234
FT                   /note="I -> V (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397..399
FT                   /note="EVI -> AVT (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403
FT                   /note="M -> T (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        419..420
FT                   /note="SA -> TP (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        425
FT                   /note="I -> L (in Ref. 1; ACW82491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        430
FT                   /note="R -> T (in Ref. 1; ACW82491 and 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        438
FT                   /note="N -> D (in Ref. 1; ACW82491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="Q -> S (in Ref. 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445..447
FT                   /note="SMT -> PMA (in Ref. 1; ACW82491 and 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        461
FT                   /note="N -> D (in Ref. 1; ACW82491 and 2; CP003191)"
FT                   /evidence="ECO:0000305"
FT   TURN            33..35
FT                   /evidence="ECO:0007744|PDB:4R3V"
FT   STRAND          43..51
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          56..58
FT                   /evidence="ECO:0007744|PDB:4R3V"
FT   HELIX           60..76
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          81..84
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   HELIX           88..90
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          92..98
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          103..105
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          108..113
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          115..118
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   TURN            121..125
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   HELIX           126..128
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          131..135
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          140..148
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   HELIX           149..161
FT                   /evidence="ECO:0007744|PDB:4IN9"
FT   STRAND          174..176
FT                   /evidence="ECO:0007744|PDB:2XS4"
FT   HELIX           186..196
FT                   /evidence="ECO:0007744|PDB:4IN9"
SQ   SEQUENCE   472 AA;  52061 MW;  4950E6623E0150B3 CRC64;
     MKRFILLFFL STIAIFKVYS QRLYDNGPLT GDNNYVLQGS KWNKTTLKYY IYNSSSHLTT
     TERENAIRSA FALWSDKSTL SFIQVYNPNQ ADIKIKWEKG NHGDGYPFDG NTGILAHAFY
     PPPAGGNYAG HLHFDGDENW SINGSGIDLI TVAAHEIGHL LGIEHSNVSS ALMYPYYTGI
     KRQLDNDDCL AVWDLYGYPF SISGPSSVCD QATYTVENLL SGATVQWSVS NPNIATINSS
     NGVLTCRGNG ICEVRATINN SSVALTPLKI CLGTPISQDI TLTVESLNSN GTLCTDNPNA
     IMADHPGGNH LGYIREYEWR ISNGWQIAHH PGDNGIYADH FIVTVIPLSP LPGSPTVSVR
     ARSECGWGTW KEVQIPAVSC SRTISPFTLS PNPATDEVIL QLMETDEVSG LSVLSTDRSA
     YEIQIWSGMR MLRSFRTNEP TFQISMTGLP AGLYFVRVVK NGQTYTQKLI KK
//
